ElendiLabs Logo
Back to Articles

Local Regulatory Experts

Connect with regulatory affairs consultancies specializing in this region.

Qualtech Consulting Corporation

Taiwan, China, Japan, Singapore, Hong Kong, Malaysia, Philippines, Vietnam, Australia, Germany, Korea, Thailand, USA

Registration

A specialized medical device consulting firm offering a one-stop solution for complex global regulatory challenges. We offer real-time regulatory and clinical support, local representation, and QMS services across 13 markets, ensuring efficient market entry and compliance.

Cobridge Co., Ltd.

Tokyo, Japan

Registration

We assist medical device companies with the medical device registration and approval in Japan. Regulatory consulting services and DMAH services for foreign manufacturers to enter Japanese market.

MDREX, Medical Device, Digital Health Consulting Group

Seoul, Republic of Korea (HQ), Japan Office

Registration
Distribution
Marketing

We offer total solutions for market entry in South Korea and global expansion (e.g., Japan, USA, Europe). Key areas include product approval, reimbursement listings (HIRA), and Quality System certification (KGMP). They are particularly strong in innovative products like SaMD, medical wearables, and 3D printing for medical use, and provide in-depth expertise in cybersecurity and clinical trial planning.

CMIC Holdings Co., Ltd.

Tokyo, Japan (HQ), Osaka, Japan, Beijing, China, Seoul, South Korea, Taipei, Taiwan, Singapore, New York, USA, London, UK, Frankfurt, Germany, Sydney, Australia

Registration
Marketing

We operate globally, specializing in accelerating the development, manufacturing, and commercialization of drugs and medical devices. Their expertise spans Phase I to IV clinical trials, regulatory affairs, quality assurance, and manufacturing, with a strong focus on the Japanese and Asian markets. Key services include clinical operations (CRO), manufacturing (CDMO/CMO), site management (SMO), and comprehensive health analysis and solutions.

View More Consultancies in This Region
Other

October 25, 2025

Approximately 5 minutes

Points to Consider for Preparation of Attached Data to Application Form for Marketing Approval of Reprocessed Single-use Medical Devices in Japan

Points to Consider for Preparation of Attached Data to Application Form for Marketing Approval of Reprocessed Single-use Medical Devices in Japan

Overview

This document titled Points to Consider for Preparation of Attached Data to Application Form for Marketing Approval of Reprocessed Single-use Medical Devices provides detailed guidance about the attached data that must accompany a marketing approval application for reprocessed single-use medical devices (R-SUDs) in Japan. The guidance was issued by the Ministry of Health, Labour and Welfare (MHLW) and applies to R-SUD applications submitted under the Pharmaceuticals and Medical Devices Act (PMD Act). ([turn0search0]; [turn0view0])

The attached data included in an application is critical for proper evaluation of product quality, safety, and equivalence to the original single-use medical device (SUD).

Structure of Attached Data

1. Product Overview

Applicants should provide a clear overview of the R-SUD, including:

  • Summary of product characteristics.
  • Development history explaining how and why the R-SUD was developed relative to the original SUD.
    These should follow formats specified in the Medical Device Attached Data Notification referenced within this guidance. ([turn0view0])

2. Design, Verification and Validation

  • Provide comprehensive design details including differences from the original SUD and rationale.
  • Include design verification and validation materials (test results, protocols, dates, and outcomes) that support safety and performance.
  • Explain any use of OEM devices as test specimens and reasons for alternative selections. ([turn0view0])

3. Comparative Analysis

  • Clearly compare the proposed R-SUD to similar devices, including the original SUD, focusing on structure, materials, use, and performance.
  • Provide data sources and justification for chosen comparators.
  • Include international usage data if the R-SUD or similar products are used outside Japan. ([turn0view0])

4. Conformity with Standards

  • Document compliance with Essential Requirements and standards for medical devices.
  • Provide checklists and attach test certificates or analysis demonstrating conformity.
  • Justify selected specifications where standards do not exist. ([turn0view0])

5. Supplementary Data

  • Include any additional supporting data that enhances clarity, such as stability data, safety risk management explanations, or unique distribution details.
  • If package inserts are required, provide draft inserts with rationale for warnings, contraindications, and precautions. ([turn0view0])

Q&A

Q: Why is attached data important for R-SUD applications?
A: Attached data provides the PMDA and reviewers with comprehensive proof of design, verification, performance, safety, and comparisons to the original SUD necessary to evaluate the application thoroughly. ([turn0search0]; [turn0view0])

Q: Must attached data include design validation results?
A: Yes. Verification and validation test records must be summarized and attached to support the product’s quality and safety claims. ([turn0view0])

Q: Can international use information be included?
A: Yes. Information about R-SUD use and approval in foreign regions helps contextualize global experience and demonstrate performance consistency. ([turn0view0])

Conclusion

Preparing attached data for an R-SUD marketing approval application requires clear product descriptions, detailed technical data, comparative analyses, conformity documentation, and supplementary evidence where necessary. Proper documentation helps ensure the PMDA can evaluate safety, efficacy, and equivalence effectively. ([turn0search0]; [turn0view0])

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550